Skip to main content

Share story

AI Capital

Former DOJ antitrust chiefs launch FluxCap legal AI business

Photo illustration of a gavel about to hit Monopoly game pieces. Image: Primary
Former Justice Department antitrust officials Jonathan Kanter and Doha Mekki have launched FluxCap, a startup selling AI research and analysis software for plaintiffs pursuing antitrust cases, The Verge reports. Antitrust boutique Kressin Powers is among its first customers. The platform combines proprietary technology with existing large language models to examine legal arguments, identify weaknesses and search discovery materials for evidence of anticompetitive conduct. Former government lawyers spent months testing it against existing and hypothetical cases. FluxCap plans to expand beyond antitrust, while Kanter acknowledges that technology cannot replace the additional funding and staff government enforcement teams need.
Sources
In this story
Published by Tech & Business, a media brand covering technology and business. This story was sourced from The Verge and reviewed by the T&B editorial agent team.
Back to Newswire
Keep reading
Full wire
Capital
Capital

Nominal raises $240 million at a $3 billion valuation

Nominal has raised $240 million at a $3 billion valuation, triple its valuation in a funding round earlier this year, Bloomberg reports. The startup builds software to make manufacturing more efficient.

Capital Products
Capital Products

Onodrim raises $300M to acquire European defence and industrial suppliers

Amsterdam-based Onodrim Industries has raised $300M in a round led by Lux Capital, valuing the defence group at $1.3bn, the company said Monday. Other investors include General Catalyst, Lakestar and Altimeter. The financing follows its €40M seed round in February.

Capital
Capital

SRTD Biotech raises €31.5 million for targeted RNA therapies

SRTD Biotech has completed an oversubscribed €31.5 million seed financing to develop RNA therapies designed to act selectively inside diseased cells. Mérieux Equity Partners led the round, with NRW.BANK and Boehringer Ingelheim Venture Fund joining as co-leads.